SCHEMBL6686098

SCHEMBL6686098

O=C(O)c1ccc(C2CCC(C(=O)O)CC2)cc1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.66
RAB9A P51151 1/20 0.66
AKR1C3 P42330 1/20 0.55
AKR1C1 Q04828 1/20 0.55
TP53 P04637 1/20 0.46
TSHR P16473 1/20 0.46
HDAC8 Q9BY41 2/20 0.44
HDAC6 Q9UBN7 2/20 0.44
PDE4A P27815 1/20 0.44
PDE4B Q07343 1/20 0.44
PDE4C Q08493 1/20 0.44
PDE4D Q08499 1/20 0.44
HDAC1 Q13547 1/20 0.44
DGAT1 O75907 1/20 0.44
SOAT1 P35610 1/20 0.44
HDAC3 O15379 1/20 0.44
HDAC11 Q96DB2 1/20 0.44
SRD5A2 P31213 2/20 0.43
MRGPRX4 Q96LA9 1/20 0.43
HAO1 Q9UJM8 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2321634 0.90 TSHR (0.57) NPC1RAB9ATP53TSHRHDAC8
SCHEMBL901207 0.90 TSHR (0.57) NPC1RAB9ATP53TSHRHDAC8
SCHEMBL901209 0.90 TSHR (0.57) NPC1RAB9ATP53TSHRHDAC8
Hydrochloric Acid SCHEMBL4290507 0.88 TSHR (0.55) NPC1RAB9ATP53TSHRHDAC8
Terephthalic Acid SCHEMBL6654100 0.88 TSHR (0.60) NPC1RAB9AAKR1C3AKR1C1TP53
SCHEMBL24087489 0.84 HDAC8 (0.56) NPC1RAB9ATP53TSHRHDAC8
SCHEMBL8536046 0.82 NPC1 (0.68) NPC1RAB9AAKR1C3AKR1C1CYP2C9
SCHEMBL28005910 0.82 ESR2 (0.59) NPC1RAB9ATP53TSHRHDAC8
SCHEMBL8999823 0.82 NPC1 (0.68) NPC1RAB9AAKR1C3AKR1C1CYP2C9
SCHEMBL664284 0.82 NPC1 (0.79) NPC1RAB9AAKR1C3AKR1C1PDE4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0856025-B1 CHOLESTERIC PHASE-FORMING POLYMERS AND THEIR USE CELANESE VENTURES GMBH (DE) 2003-01-15 EP claimed
CN-103664581-B A kind of anti-, trans-4, the preparation method of 4 '-dicyclohexyl dioctyl phthalate 中节能万润股份有限公司 2016-07-06 CN disclosed
US-20150080546-A1 Production and Use of 3,4' and 4,4'-Dimethylbiphenyl Isomers EXXONMOBIL CHEMICAL PATENTS INC. 2015-03-19 US disclosed
EP-2808325-A1 Substituted azoles, anti-viral active ingredient, pharmaceutical composition, method for the production and use thereof Alla Chem, LLC. (US) 2014-12-03 EP disclosed
CN-103664581-A Preparation method of trans,trans-4,4'-dicyclohexyl phthalate YANTAI VALIANT FINE CHEMICALS CO LTD 2014-03-26 CN disclosed
EP-2657231-A2 SUBSTITUTED AZOLES, ANTI-VIRAL ACTIVE INGREDIENT, PHARMACEUTICAL COMPOSITION, METHOD FOR THE PRODUCTION AND USE THEREOF Ivachtchenko, Alexandre Vasilievich (US) 2013-10-30 EP disclosed
US-20130253008-A1 SUBSTITUTED AZOLES, ANTIVIRAL ACTIVE COMPONENT, PHARMACEUTICAL COMPOSITION, METHOD FOR PREPARATION AND USE THEREOF ALLA CHEM LLC (US) 2013-09-26 US disclosed
US-20130253008-A1 SUBSTITUTED AZOLES, ANTIVIRAL ACTIVE COMPONENT, PHARMACEUTICAL COMPOSITION, METHOD FOR PREPARATION AND USE THEREOF ALLA CHEM LLC (US) 2013-09-26 US disclosed
WO-2012074437-A2 SUBSTITUTED AZOLES, ANTI-VIRAL ACTIVE INGREDIENT, PHARMACEUTICAL COMPOSITION, METHOD FOR THE PRODUCTION AND USE THEREOF АЛЛА ХЕМ, ЛЛС (US) 2012-06-07 WO disclosed
US-20110250509-A1 SECONDARY BATTERY AND ELECTRONIC DEVICE SONY CORPORATION (JP) 2011-10-13 US disclosed
CN-100442092-C Optical film and liquid crystal display element NIPPON OIL CORP (JP) 2008-12-10 CN disclosed
CN-100442092-C Optical film and liquid crystal display element NIPPON OIL CORP (JP) 2008-12-10 CN disclosed
CN-1759334-A Optical film and liquid crystal display element NIPPON OIL CORP (JP) 2006-04-12 CN disclosed
CN-1759334-A Optical film and liquid crystal display element NIPPON OIL CORP (JP) 2006-04-12 CN disclosed
JP-2004272110-A OPTICAL FILM AND LIQUID CRYSTAL DISPLAY ELEMENT NIPPON OIL CORP 2004-09-30 JP disclosed
WO-2004081623-A1 OPTICAL FILM AND LIQUID CRYSTAL DISPLAY DEVICE NIPPON OIL CORPORATION (JP) 2004-09-23 WO disclosed
EP-0856025-B1 CHOLESTERIC PHASE-FORMING POLYMERS AND THEIR USE CELANESE VENTURES GMBH (DE) 2003-01-15 EP disclosed
US-6107447-A LIQUID CRYSTALLINE POLYMERS HOECHST RESEARCH TECHNOLOGY DEUTCHLAND GMBH & CO. KG (DE) 2000-08-22 US disclosed
EP-0856025-A1 CHOLESTERIC PHASE-FORMING POLYMERS, PROCESS FOR THEIR PREPARATION AND THEIR USE Hoechst Research & Technology Deutschland GmbH & Co. KG (DE) 1998-08-05 EP disclosed
WO-1997014739-A1 CHOLESTERIC PHASE-FORMING POLYMERS, PROCESS FOR THEIR PREPARATION AND THEIR USE HOECHST RESEARCH & TECHNOLOGY (DE) 1997-04-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150080546-A1 Production and Use of 3,4' and 4,4'-Dimethylbiphenyl Isomers CYP4B1, HPD, DDT NPC1 4871/4885RAB9A 4370/4885AKR1C3 187/4885
US-20130253008-A1 SUBSTITUTED AZOLES, ANTIVIRAL ACTIVE COMPONENT, PHARMACEUTICAL COMPOSITION, METHOD FOR PREPARATION AND USE THEREOF HCCS, EIF2AK2, HAVCR2 NPC1 1122/4885RAB9A 4117/4885AKR1C3 101/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.